CGH - Comparative Genomic Hybridization		ARRAY CGC for Craniosynostosis		ARRAY CGC for NonSyndromic Congenital Hearing Loss		Psychomotor Development Delay
Traditionally, diagnosis of genetic causes of mental retardation (also referred to as developmental delay) has depended upon cytogenetic and/or FISH analysis of deletion syndromes. Recent technological advances have demonstrated the existence of many additional genetic variations/micro-deletion syndromes that cannot be detected by cytogenetics. A microarray-based system known as comparative genomic hybridization (CGH)...		This is a brief description of the advantages of complementing clinical diagnosis (including prenatal diagnosis), in all cases where there is an evidence of Craniosynostosis, by performing the molecular testing for the most frequent syndromes presenting this symptom, using a new microarray technology...		This is a description of the advantages of using new Microarray technology to complement clinical diagnosis in all cases where there is an evidence of nonsyndromic congenital hearing loss. This technology identifies in a single test, the most frequent genes and mutations associated with this clinical diagnosis.		The psychomotor development delay is one of the clinically situations in which is difficult to find the etiopathogenesis. GCC Genetics has developed a new strategy based on a sequential approach, with results in one to two weeks for each step...

ARRAY CGC for Skeletal Dysplasia		ARRAY CGC for Trombophilia and Warfarin Pharmacogenetics		PND plus+		CGC Award Professor Doutor Amândio Tavares 2009
This is a brief description of the advantages of complementing prenatal clinical diagnosis, where there is no conclusive diagnosis of a specific foetal skeletal dysplasia, by performing the molecular diagnosis for the more frequent skeletal diseases, using a new microarray technology...		This is a brief description of the molecular screening test for hereditary thrombophilia and warfarin pharmacogenetics, using a new MicroArray technology.		Prenatal Diagnosis plus+, developed by the CGC Genetics R&D team, offers a panel of options, using several methods, including microarrays, that could complement or complete the conventional prenatal diagnosis. The set of disorders included were defined according to the potential for disease prevention, early treatment / intervention and health care improvement...		CGC Genetics Award ‘Professor Doutor Amândio Tavares’, created in June 2006 to reward innovation works in the field of Medical Genetics, was delivered June 29th, during the 17th Conference SinASE, by the President of the Portuguese Parliamentary Health Commission, Dr. Maria de Belém Roseira...

Array CGC for Syndromic Congenital Hearing Loss		CGC is licensed in the State of California		GENETIC TESTS at CGC Centro de Genética Clínica		Arrays CGC (Patent Pending)
This is a description of the advantages of using new Microarray technology to complement clinical diagnosis in all cases where there is an evidence of syndromic congenital hearing loss. This technology identifies in a single test, the most frequent genes and mutations associated with this clinical diagnosis.		CGC's license for the State of California was approved last January by California Department of Public Health (CDPH)...		Genetic tests are nowadays presented as tests of easy access, for clinical and non-clinical applications, frequently raising questions about its real utility and medical application. Therefore, CGC intends to provide the following clarifications to all interested in our services...		The new microarray tests offered by CGC genetics provide a method of achieving a fast, cost-effective diagnosis of diseases with genetic background, using a unique approach. This breakthrough utilizes clinical features of the disease and its differential diagnosis, to define logical panels to study arranged by groups of signs or symptoms of the diseases.

CGC in Health Cluster Portugal		CGC wins in two categories of Hospital do Futuro Awards 2007-2008		CGC Centro de Genética Clínica in COTEC Innovative SMEs Network		Porto City Hall Magazine
CGC Centro de Genética Clínica (CGC), the first private medical genetics laboratory in Portugal, is one of the sixty-eight institutions that constitute the competitiveness and technology pole - Health Cluster Portugal (HCP). The main objective of HCP is...		In this year’s edition, Hospital do Futuro Awards received 178 appplications from 84 institutions of the Healthcare Sector. There were 12 different contest categories, CGC won in two categories...		CGC Centro de Genética Clínica belongs since 2007 to COTEC Innovative SMEs Network. The aim of this initiative is...		Porto City Hall distinguished CGC with an article in its magazine PORTO sempre, entitled ?Genetic information born in Porto?, after the visit of Eng.º Vladimiro Feliz, City Councilman of Education, Youth and Innovation to CGC facilities.